Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simiaowan for gout flare prevention during febuxostat initiation
NCT04069325Unknown
- Sponsor
- Guang'anmen Hospital
- Start
- Sep 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of si miao san in gout, sponsored by Guang'anmen Hospital. Primary endpoint: Proportion of subjects experiencing >= 1 gout flare at 12 weeks. Status: unknown.
02
Drugs
si miao san
03
Conditions
gout
Beyond the preview
Go deeper on NCT04069325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04069325.